Centuries ago, the human body was only treated for visible external injuries and cures
based on experience with foods and plants for known symptoms. The knowledge of biological
nature of human body only evolved over last 100 years.
Biology is fundamentally molecular. However, lacking detail molecular knowledge, the ability of treating patients did not reach cell and sub cell level until recently. The ongoing research in genomic and related fields is providing detailed knowledge of the human body at the molecular level.
Over past 10 years engineering has caught up with biology. At many research labs and universities across the globe, scientist and engineers have made tremendous progress in nanotechnology. The combination of these two advances provides an opportunity to understand disease at molecular level and treat them at the nano-scale level
OmegaGenesis is developing suitable nano-materials to manage human body functions at nano scale - the cell and sub-cell level -- accelerating cellular-based biologic therapies where the growth of blood cells determines the outcome. These nano-materials will enable Doctors to treat disease at sub-cell level in a non-destructive manner instead of treating the disease at the organ or tissue level. It is now possible to look inside a cell to stimulate the organic growth of blood cells in constructive conditions or inhibit the expansion of blood cells to stop destructive growth.
Biology is fundamentally molecular. However, lacking detail molecular knowledge, the ability of treating patients did not reach cell and sub cell level until recently. The ongoing research in genomic and related fields is providing detailed knowledge of the human body at the molecular level.
Over past 10 years engineering has caught up with biology. At many research labs and universities across the globe, scientist and engineers have made tremendous progress in nanotechnology. The combination of these two advances provides an opportunity to understand disease at molecular level and treat them at the nano-scale level
OmegaGenesis is developing suitable nano-materials to manage human body functions at nano scale - the cell and sub-cell level -- accelerating cellular-based biologic therapies where the growth of blood cells determines the outcome. These nano-materials will enable Doctors to treat disease at sub-cell level in a non-destructive manner instead of treating the disease at the organ or tissue level. It is now possible to look inside a cell to stimulate the organic growth of blood cells in constructive conditions or inhibit the expansion of blood cells to stop destructive growth.
Angiogenesis is the formation of new blood vessels from pre-existing vessels. Angiogenesis is
a process controlled by certain chemicals produced in the body. Some of these chemicals stimulate
cells to repair damaged blood vessels or form new ones. Other chemicals, called angiogenesis
inhibitors, signal the process to stop.
Human body management applications where blood cells greatly determine the outcome range from cancer and malignancies treatments to common wound healing and tissue reactivation.
Therapeutic angiogenesis is the application of specific compounds or nano-materials which may inhibit or induce the creation of new blood vessels in the body in order to combat disease.
OmegaGenesis scientists are actively working with nano-materials to successfully facilitate the pro-angiogenesis process and are studying natural and synthetic angiogenesis inhibitors also called anti-angiogenesis agents, with the expectation these materials will prevent or slow down the growth of cancer and malignancies by blocking the formation of new blood vessels.
Human body management applications where blood cells greatly determine the outcome range from cancer and malignancies treatments to common wound healing and tissue reactivation.
Therapeutic angiogenesis is the application of specific compounds or nano-materials which may inhibit or induce the creation of new blood vessels in the body in order to combat disease.
OmegaGenesis scientists are actively working with nano-materials to successfully facilitate the pro-angiogenesis process and are studying natural and synthetic angiogenesis inhibitors also called anti-angiogenesis agents, with the expectation these materials will prevent or slow down the growth of cancer and malignancies by blocking the formation of new blood vessels.
Angiogenesis is the formation of new blood vessels. Angiogenesis is a
process controlled by certain chemicals produced in the body.
Some of these chemicals stimulate cells to repair damaged blood vessels or form new ones. Other chemicals, called angiogenesis inhibitors or anti-angiogenesis, signal the process to stop.
Why is Angiogenesis Important?
Angiogenesis plays an important role ranging from tissue reactivation and healing of common wounds to controlling the growth and spread of cancer and malignancies. In cancer and malignancies, new blood vessels "feed" the cancer cells with oxygen and nutrients, allowing these cells to grow, invade nearby tissue, spread to other parts of the body, and form new colonies of cancer cells.How Does Angiogenesis Address Cancer?
Because tumors are nutrition- and oxygen-dependent, thus being in need of adequate blood supply, tumors cannot grow or spread without the formation of new blood vessels. Scientists are researching ways to stop angiogenesis and are studying natural and synthetic angiogenesis inhibitors, also called anti-angiogenic agents. The field of anti-angiogenesis is the scientific area where the application of nano-materials is expected to prevent or slow down the growth of cancer and malignancies by blocking the formation of new blood vessels.What other Applications Exist for Angiogenesis?
Whereas anti-angiogenic therapies are trying to fight cancer and malignancies, the pro-angiogenic therapies are becoming more and more important in the search of new treatment options for cardiovascular diseases (the number one cause of death in the Western world) and more common wound healing and tissue reactivation applications.The applications under research and therapies being developed by OmegaGenesis address four significant global medical applications:
1. Angiogenesis - New blood vessels creation and growth
2. Anti-Angiogenesis -- Reduce or stop blood vessels growth
3. Medical Imaging -- Provide precise, fast and effective imaging materials
4. Diagnostic and Delivery Agents: Facilitate diagnostics by sub-cell reach of nano materials